AKT1 and Alzheimer disease: In summary, we reviewed the relationship between the PDK1/Akt signaling pathway and AD and discussed the possibility that reducing the rate of activation of PDK1/Akt can prevent Aβ-mediated neuronal toxicity by suppressing the expression of TACE in the cell membrane.